Search Within

Vasilisa A. Rudneva

Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (5)
  3. Surgery (5)
  4. Department of Pathology and Laboratory Medicine (4)
  5. Division of Subspecialty Medicine (3)
  6. GSK Faculty (3)

More Groups

People
  1. Mark Donoghue (3)
  2. Alison Schram (2)
  3. Allison Richards (2)
  4. Andrew Lin (2)
  5. Eliza Geer (2)
  6. Marc Cohen (2)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (1)
  4. 2021 (3)
Publications
  1. Journal of Clinical Oncology (2)
  2. Acta Neuropathologica (1)
  3. Clinical Cancer Research (1)
  4. JAMA Oncology (1)
  5. Journal of the Endocrine Society (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. American Medical Association (1)
  4. Endocrine Society (1)
  5. Springer (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic analysis of paired primary and metastatic pancreatic ductal adenocarcinoma tumors
    Meeting Abstract

    McIntyre, C. A.; Rudneva, V.; Richards, A. L.; Park, W.; Jarnagin, W. R.; Donoghue, M.; O'Reilly, E. M.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
    Journal Article

    Lin, A. L.; Rudneva, V. A.; Richards, A. L.; Zhang, Y.; Woo, H. J.; Cohen, M.; Tisnado, J.; Majd, N.; Wardlaw, S. L.; Page-Wilson, G.; more...
    Acta Neuropathologica (2024)

    Fulltext@MSK | Save
  • Avelumab plus talazoparib in patients with BRCA1/2- or ATM-altered advanced solid tumors: Results from JAVELIN BRCA/ATM, an open-label, multicenter, phase 2b, tumor-agnostic trial
    Journal Article

    Schram, A. M.; Colombo, N.; Arrowsmith, E.; Narayan, V.; Yonemori, K.; Scambia, G.; Zelnak, A.; Bauer, T. M.; Jin, N.; Ulahannan, S. V.; more...
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Improved survival among patients with malignant pleural mesotheliomas who develop immune-related adverse events on immunotherapy
    Meeting Abstract

    Offin, M.; Egger, J. V.; McCarthy, C. G.; Rudneva, V.; Beattie, J.; Ginsberg, M. S.; Sauter, J. L.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Synergism of checkpoint inhibitors and peptide receptor radionuclide therapy in the treatment of pituitary carcinoma
    Journal Article

    Lin, A. L.; Tabar, V.; Young, R. J.; Cohen, M.; Cuaron, J.; Yang, T. J.; Rosenblum, M.; Rudneva, V. A.; Geer, E. B.; Bodei, L.
    Journal of the Endocrine Society (2021)

    Fulltext@MSK | Save
  • Comprehensive molecular and clinicopathologic analysis of 200 pulmonary invasive mucinous adenocarcinomas identifies distinct characteristics of molecular subtypes
    Journal Article

    Chang, J. C.; Offin, M.; Falcon, C.; Brown, D.; Houck-Loomis, B. R.; Meng, F.; Rudneva, V. A.; Won, H. H.; Amir, S.; Montecalvo, J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save